Pricing Log in Create free account

Lexeo Therapeutics, Inc. (LXEO) vs Q32 Bio Inc. (QTTB)

Lexeo Therapeutics, Inc. and Q32 Bio Inc. are both Biotechnology companies. Lexeo Therapeutics, Inc. and Q32 Bio Inc. are of similar size ($231.3M and $226.6M). Lexeo Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 2.5×. Across the 11 metrics below, Q32 Bio Inc. leads on 10 and Lexeo Therapeutics, Inc. on 1.

Valuation

Metric LXEO QTTB Biotechnology median
P/E n/m 2.49 8.50
P/S n/m n/m 9.71
P/B 0.96 1.44 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m (8.25) 9.21
Earnings yield (43.56%) 40.16% (33.15%)
Free cash flow yield (39.24%) (8.43%) (25.50%)

Profitability

Metric LXEO QTTB Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (46.76%) 72.14% (56.36%)
Return on assets (40.50%) 37.13% (48.04%)
Return on invested capital (253.48%) 0.00% 0.00%

Growth

Metric LXEO QTTB Biotechnology median
Revenue growth (TTM) — (307.33%) 6.02%
EPS growth (last fiscal year) 39.81% 148.96% 30.26%
Revenue growth, 5-year CAGR — 100.32% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LXEO QTTB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.89 20.30 4.72
Net debt to EBITDA 1.67 (2.21) 0.96

Dividend

Metric LXEO QTTB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LXEO QTTB Biotechnology median
Market cap 226.56m 231.31m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack